Sandro Wealth Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$513K Buy
8,480
+2,025
+31% +$142K 0.33% 65
2026
Q2
$451K Buy
+6,455
New +$472K 0.33% 64

Other funds holding NKTR

Sandro Wealth Management's NKTR Position: Q3 2026 in Review

Sandro Wealth Management increased its Nektar Therapeutics (NKTR) stake by 31% in Q3 2026, buying an estimated $142K and bringing the position to 8,480 shares worth $513K. The position accounts for 0.33% of the portfolio, ranked #65.

Sandro Wealth Management first reported a position in NKTR in Q2 2026 and has held it in 2 quarters since. 243 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.

  • Sandro Wealth Management held 8,480 shares of Nektar Therapeutics worth $513K as of Q3 2026.
  • Sandro Wealth Management bought 2,025 Nektar Therapeutics shares in Q3 2026, an estimated $142K.
  • Nektar Therapeutics made up 0.33% of Sandro Wealth Management's portfolio in Q3 2026, its #65 holding.
  • Sandro Wealth Management first reported a position in Nektar Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 243 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.

Based on Sandro Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.